ReGear Life Sciences is ready to take off.
Developer
of cutting-edge sport medicine therapy that penetrates deep below the
tissue to treat chronic pain, soft tissue, repetitive stress injuries
and more, the company has recently grown from three to nine and plans
to double to 18 by the end of the year.
An infusion of funding is forthcoming as well. ReGear has raised $2 million–$225,000 from PLSG, $300,000 from Innovation Works
and another $1.5 million from private investors. Another $1 million is
in process from an undisclosed local institutional investor. ReGears
market size is stands at $3 billion.
Read the full story on Pop City.
